Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
Authors
Keywords
Gene expression profiling, DecisionDx-Melanoma, Cutaneous melanoma, Metastasis, Prognosis, Staging
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-05
DOI
10.1186/s12885-018-4016-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
- (2017) Eddy C. Hsueh et al. Journal of Hematology & Oncology
- Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013
- (2017) Shoshana M. Landow et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- NCCN Molecular Testing White Paper: Effectiveness, Efficiency, and Reimbursement
- (2017) Paul F. Engstrom et al. Journal of the National Comprehensive Cancer Network
- NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
- (2017) Phillip G. Febbo et al. Journal of the National Comprehensive Cancer Network
- Melanoma, Version 4.2014
- (2017) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma
- (2015) P. Gerami et al. CLINICAL CANCER RESEARCH
- More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
- (2015) David C. Whiteman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
- (2015) Pedram Gerami et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Melanoma Thickness and Survival Trends in the United States, 1989–2009
- (2015) Waqas R. Shaikh et al. JNCI-Journal of the National Cancer Institute
- Melanoma Thickness and Survival Trends in the United States, 1989–2009
- (2015) Waqas R. Shaikh et al. JNCI-Journal of the National Cancer Institute
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
- (2014) Donald L. Morton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma
- (2012) Michael D. Onken et al. OPHTHALMOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started